Rapivab 600 mg/60mL
peramivir · SOLUTION · BioCryst Pharmaceuticals, Inc.
No Recall History
Plain English
Rapivab is a solution containing peramivir at 600 mg/60mL, taken intravenous. Manufactured by BioCryst Pharmaceuticals, Inc..
Key Facts
- Brand Name
- Rapivab
- Generic Name
- peramivir
- NDC Code (Product)
72769-181- Manufacturer
- BioCryst Pharmaceuticals, Inc.
- Strength
- 600 mg/60mL
- Dosage Form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA206426
- Drug Class
- Neuraminidase Inhibitor [EPC]
- Marketing Start
- 12/20/2014
Recall History
No Recall HistoryFrequently Asked Questions
What is Rapivab used for?
Rapivab contains peramivir. It is a solution taken intravenous. Consult your doctor for specific uses.
Is Rapivab a controlled substance?
Rapivab is not classified as a controlled substance by the DEA.
What is the generic name for Rapivab?
The generic name for Rapivab is peramivir. There are no other listed brand versions of peramivir.
What is the NDC code for Rapivab 600 mg/60mL?
The NDC (National Drug Code) for Rapivab 600 mg/60mL is 72769-181, listed by BioCryst Pharmaceuticals, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)